Cedars-Sinai Medical Center Gynecologic Oncology

Topics

• Ovarian cancer diagnosis and treatment 52
• Endometrial and Cervical Cancer Treatments 32
• Economic and Financial Impacts of Cancer 30
• Cervical Cancer and HPV Research 13
• PARP inhibition in cancer therapy 13
• BRCA gene mutations in cancer 10
• Uterine Myomas and Treatments 9
• Cancer survivorship and care 7
• Diversity and Career in Medicine 7
• Cancer, Lipids, and Metabolism 6
• Pregnancy and preeclampsia studies 6
• Enhanced Recovery After Surgery 4

Most cited

1. HBO1 catalyzes lysine lactylation and mediates histone H3K9la to regulate gene transcription.

   Nature communications · 2024 · 225 citations · Yingao Zhang

2. A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 358 citations · Emily Prendergast

3. Navigating financial toxicity in patients with cancer: A multidisciplinary management approach.

   CA: a cancer journal for clinicians · 2022 · 245 citations · Margaret Liang

4. Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.

   The Lancet. Oncology · 2023 · 172 citations · Christine Holschneider

5. Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 42 citations · Emily Prendergast

6. Immune evasion in ovarian cancer: implications for immunotherapy and emerging treatments.